[go: up one dir, main page]

SV2008002542A - Formas solidas cristalinas de tigeciclina y metodos para preparar los mismos ref. 01142.0379-00267 (am101946sv) - Google Patents

Formas solidas cristalinas de tigeciclina y metodos para preparar los mismos ref. 01142.0379-00267 (am101946sv)

Info

Publication number
SV2008002542A
SV2008002542A SV2006002542A SV2006002542A SV2008002542A SV 2008002542 A SV2008002542 A SV 2008002542A SV 2006002542 A SV2006002542 A SV 2006002542A SV 2006002542 A SV2006002542 A SV 2006002542A SV 2008002542 A SV2008002542 A SV 2008002542A
Authority
SV
El Salvador
Prior art keywords
tigecicline
prepare
am101946sv
methods
crystalline forms
Prior art date
Application number
SV2006002542A
Other languages
English (en)
Inventor
Lalitha Krishnan
Subodh S Deshmukh
Anthony F Hadfield
W James Huang
Mannching Sherry Ku
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37026996&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SV2008002542(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of SV2008002542A publication Critical patent/SV2008002542A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/22—Separation; Purification; Stabilisation; Use of additives
    • C07C231/24—Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/24—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
    • C07C237/26—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton of a ring being part of a condensed ring system formed by at least four rings, e.g. tetracycline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/40—Ortho- or ortho- and peri-condensed systems containing four condensed rings
    • C07C2603/42—Ortho- or ortho- and peri-condensed systems containing four condensed rings containing only six-membered rings
    • C07C2603/44—Naphthacenes; Hydrogenated naphthacenes
    • C07C2603/46—1,4,4a,5,5a,6,11,12a- Octahydronaphthacenes, e.g. tetracyclines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pathology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)

Abstract

SE DESCRIBEN EN LA PRESENTE LAS FORMAS SOLIDAS CRISTALINAS DE TIGECICLINA, FORMA I, FORMA II, FORMA III, FORMA IV Y FORMA V, COMPOSICIONES QUE COMPRENDEN ESTAS FORMAS SÓLIDAS CRISTALINAS, Y PROCESOS PARA PREPARAR ESTAS FORMAS SÓLIDAS CRISTALINAS
SV2006002542A 2005-05-27 2006-05-25 Formas solidas cristalinas de tigeciclina y metodos para preparar los mismos ref. 01142.0379-00267 (am101946sv) SV2008002542A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68495505P 2005-05-27 2005-05-27

Publications (1)

Publication Number Publication Date
SV2008002542A true SV2008002542A (es) 2008-02-22

Family

ID=37026996

Family Applications (1)

Application Number Title Priority Date Filing Date
SV2006002542A SV2008002542A (es) 2005-05-27 2006-05-25 Formas solidas cristalinas de tigeciclina y metodos para preparar los mismos ref. 01142.0379-00267 (am101946sv)

Country Status (27)

Country Link
US (1) US8372995B2 (es)
EP (1) EP1890996B1 (es)
JP (2) JP2008545717A (es)
KR (1) KR20080016890A (es)
CN (1) CN101248038B (es)
AR (1) AR057649A1 (es)
AU (1) AU2006251954A1 (es)
BR (1) BRPI0610653A2 (es)
CA (1) CA2609875C (es)
CL (1) CL2006001266A1 (es)
CR (1) CR9540A (es)
DK (1) DK1890996T3 (es)
EC (1) ECSP078055A (es)
ES (1) ES2415518T3 (es)
GT (1) GT200600227A (es)
IL (1) IL187359A (es)
MX (1) MX2007014735A (es)
NO (1) NO20076005L (es)
PE (1) PE20070024A1 (es)
PL (1) PL1890996T3 (es)
PT (1) PT1890996E (es)
RU (1) RU2478612C2 (es)
SI (1) SI1890996T1 (es)
SV (1) SV2008002542A (es)
TW (1) TWI421232B (es)
WO (1) WO2006128150A2 (es)
ZA (1) ZA200710151B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070244335A1 (en) * 2006-04-17 2007-10-18 Teva Pharmaceutical Industries Ltd. Isolation of tetracycline derivatives
US8198470B2 (en) 2006-04-24 2012-06-12 Teva Pharmaceutical Industries Ltd. Crystalline form II of tigecycline and processes for preparation thereof
DE202007019460U1 (de) * 2006-04-24 2012-10-24 Teva Pharmaceutical Industries Ltd. Kristalline Tigecyclin-Formen
US8198469B2 (en) * 2006-11-29 2012-06-12 Teva Pharmaceutical Industries Ltd. Crystalline forms of tigecycline and processes for preparation thereof
BRPI0706517A2 (pt) * 2006-11-30 2011-03-29 Teva Pharma processos para preparação de f 9-haloacetamidominociclinas
PT103661B (pt) * 2007-02-23 2010-09-07 Hovione Farmaciencia S A Processo de preparação de minociclina base cristalina
WO2008106234A1 (en) * 2007-03-01 2008-09-04 Teva Pharmaceutical Industries Ltd. Processes for purification of tigecycline
AT13157U1 (de) * 2007-04-24 2013-07-15 Teva Pharma Tigecyclin, kristalline Formen und Herstellungsverfahren dafür
EP2178827A1 (en) 2007-06-21 2010-04-28 Sandoz AG Crystalline solid forms
US20100256402A1 (en) * 2007-11-14 2010-10-07 Sandoz Ag Novel solvate
ES2532880T3 (es) * 2007-11-14 2015-04-01 Sandoz Ag Formas cristalinas del Clorhidrato de Tigeciclina
WO2009070799A1 (en) * 2007-11-29 2009-06-04 Teva Pharmaceutical Industries Ltd. Processes for preparation of crystalline tigecycline form ii
US20110124893A1 (en) * 2008-01-23 2011-05-26 Sandoz Ag Antibiotic compounds
ITMI20080807A1 (it) 2008-05-05 2009-11-06 Antibioticos Spa Procedimento per la preparazione di tigeciclina in forma amorfa
TW202332671A (zh) * 2008-05-19 2023-08-16 美商Ｐｒｔｋ Ｓｐｖ２公司 四環素化合物之甲苯磺酸鹽及同素異形體
CA2746585C (en) 2008-12-18 2017-08-29 Sandoz Ag Crystalline form c of tigecycline dihydrochloride and methods for its preparation
PT104350A (pt) 2009-01-23 2010-07-23 Hovione Farmaci Ncia S A Processo de isolamento de tigeciclina
CN102746183B (zh) * 2011-04-20 2014-12-17 胡梨芳 替加环素结晶水合物及其制备方法和用途
CN102295576A (zh) * 2011-06-29 2011-12-28 赵军旭 替加环素的晶型及其制备方法
CN102898325B (zh) * 2011-07-29 2015-07-08 江苏奥赛康药业股份有限公司 替加环素晶体及其制备方法
CN102924322B (zh) * 2012-11-05 2014-09-17 赵军旭 一种替加环素的新晶型及其制备方法
CN103833590A (zh) * 2012-11-26 2014-06-04 石药集团中奇制药技术（石家庄）有限公司 替加环素晶型及其制备方法
TWI656116B (zh) * 2016-06-22 2019-04-11 山東亨利醫藥科技有限責任公司 Crystal form of 9-aminomethyl substituted tetracycline compound and preparation method thereof
CA3196954A1 (en) 2020-11-03 2022-05-12 Josep Bassaganya-Riera Crystalline forms of piperazine-1,4-diylbis((6-(1h-benzoi[d]imidazo-2-yl)pyridin-2yl)methanone) as lancl2 modulators
TWI843989B (zh) 2021-02-19 2024-06-01 美商美威高能離子醫療系統公司 用於粒子治療系統之支架

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT536515E (pt) 1991-10-04 2002-05-31 American Cyanamid Co Novas 7-substituido-9-(amino substitido)-6-desmetil-6-desoxitetraciclinas
US5420272A (en) 1992-08-13 1995-05-30 American Cyanamid Company 7-(substituted)-8-(substituted)-9-](substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines
US5328902A (en) 1992-08-13 1994-07-12 American Cyanamid Co. 7-(substituted)-9-[(substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines
US5284963A (en) 1992-08-13 1994-02-08 American Cyanamid Company Method of producing 7-(substituted)-9-[(substituted glycyl)-amidol]-6-demethyl-6-deoxytetra-cyclines
SG47520A1 (en) 1992-08-13 1998-04-17 American Cyanamid Co New method for the production of 9-amino-6-demethyl-6-deoxytetracycline
US5675030A (en) * 1994-11-16 1997-10-07 American Cyanamid Company Method for selective extracting a 7-(hydrogen or substituted amino)-9- (substituted glycyl) amido!-6-demethyl-6-deoxytetracycline compound
NZ519984A (en) * 2000-01-07 2004-03-26 Transform Pharmaceuticals Inc High-throughput formation, identification, and analysis of diverse solid-forms
CN102512429A (zh) * 2005-03-14 2012-06-27 惠氏公司 替加环素组合物及制备方法
AR057324A1 (es) * 2005-05-27 2007-11-28 Wyeth Corp Tigeciclina y metodos para preparar 9-aminominociclina
AR057034A1 (es) * 2005-05-27 2007-11-14 Wyeth Corp Metodos para purificar tigeciclina
AR057033A1 (es) * 2005-05-27 2007-11-14 Wyeth Corp Tigeciclina y metodos para preparar 9-nitrominociclina
AR057032A1 (es) * 2005-05-27 2007-11-14 Wyeth Corp Tigeciclina y metodos de preparacion

Also Published As

Publication number Publication date
AU2006251954A1 (en) 2006-11-30
JP2013100354A (ja) 2013-05-23
CL2006001266A1 (es) 2008-05-16
HK1113786A1 (en) 2008-10-17
ES2415518T3 (es) 2013-07-25
JP2008545717A (ja) 2008-12-18
CN101248038A (zh) 2008-08-20
SI1890996T1 (sl) 2013-06-28
MX2007014735A (es) 2008-02-15
BRPI0610653A2 (pt) 2010-07-13
CR9540A (es) 2008-02-21
NO20076005L (no) 2008-02-22
US20070123497A1 (en) 2007-05-31
RU2007143160A (ru) 2009-07-10
IL187359A (en) 2013-04-30
EP1890996B1 (en) 2013-04-24
ZA200710151B (en) 2010-05-26
IL187359A0 (en) 2008-04-13
DK1890996T3 (da) 2013-05-13
WO2006128150A3 (en) 2007-03-08
TW200720232A (en) 2007-06-01
CA2609875C (en) 2014-01-07
PL1890996T3 (pl) 2013-08-30
TWI421232B (zh) 2014-01-01
GT200600227A (es) 2007-01-12
PT1890996E (pt) 2013-06-24
CN101248038B (zh) 2014-03-05
US8372995B2 (en) 2013-02-12
ECSP078055A (es) 2008-01-23
AR057649A1 (es) 2007-12-12
WO2006128150A2 (en) 2006-11-30
EP1890996A2 (en) 2008-02-27
KR20080016890A (ko) 2008-02-22
PE20070024A1 (es) 2007-02-06
RU2478612C2 (ru) 2013-04-10
CA2609875A1 (en) 2006-11-30

Similar Documents

Publication Publication Date Title
SV2008002542A (es) Formas solidas cristalinas de tigeciclina y metodos para preparar los mismos ref. 01142.0379-00267 (am101946sv)
CR9723A (es) Nueva forma cristalina de un derivado de piridazino[4,5-b] indol
ECSP10010129A (es) Inhibidores de quinasas símil polo
ECSP099529A (es) Inhibidores de cinasa mapk/erk
AR069474A1 (es) Material anticorrosivo
ECSP077271A (es) Derivados de pirimidina
CY1112653T1 (el) Κρυσταλλικες τροποποιησεις της πυρακλοστροβινης
GT201000047A (es) Mejoras en compuestos organicos o relacionadas con los mismos
ECSP10010344A (es) Azolilmetiloxiranos, su uso y agentes que los contienen
GT201000061A (es) Derivados de uracilo o timina para el tratamiento de hepatitis c
ECSP077259A (es) Derivados de pirimidina
BRPI0606318A2 (pt) composto, composição, e, uso de um composto
MX375111B (es) Fenil acetato de l-ornitina y métodos para elaborar el mismo.
DK1893587T3 (da) Fremgangsmåde til fremstilling af dihydroquinazoliner
CL2010001348A1 (es) Compuestos derivados de 1-oxo-2,3-dihidro-1h-isoindolin-5-il)-isoxazol-3-carboxamida, potenciadores de los mglur2; composicion farmaceutica; y su uso para aliviar los sintomas o disminuir la aparicion de los sintomas de ezquizofrenia o ansiedad.
GT200600346A (es) Nueva fórmula cristalina v de la agomelatina, un proceso para su preparación y composiciones farmacéuticas que la contienen
HN2008000088A (es) Heterociclicos de 1,4-dihidropiridina- fusionada, procesos para preparar los mismos, su uso y las composiciones que los contienen.
PA8577201A1 (es) 3-fenil-propionamido, 3-fenil-acrilamido y derivados 3-fenil-propinamido como inhibidores de mao-b
CR8559A (es) Pirazolopirimidinas
AR058501A1 (es) Composiciones azeotropicas que comprenden 1,1,1,2,3- pentalfluoropeno y fluoruro de hidrogeno y sus usos
GT200600520A (es) Agentes antibacterianos
CR9853A (es) Compuestos de exemestano (s)-6-metiloxaalquilo y metodos relacionados con su utilizacion
ECSP109874A (es) Nuevos compuestos 892
DK1658062T3 (da) Alfa-aminoamid-derivater anvendelige som anti-inflammatoriske midler
GT200600173A (es) Forma purificada de tranaproget